Dictionary

The Dictionary provides concise definitions of health economics terms, arranged alphabetically for quick reference. Use it to understand unfamiliar terminology or confirm the meaning of a specific term.

101–150 of 152 terms matching “HAS”

P

Peto TestPeto Log-Rank Test, Peto Method
A Peto–Peto weighted test for comparing time-to-event distributions, using observed-versus-expected events with weights based on pooled survival that emphasize earlier event times.
Pivotal TrialRegistration-Enabling Trial, Licensing Trial
A trial, typically phase III, whose results form the primary basis for a regulatory approval decision, showing significant and meaningful efficacy.
Positive Likelihood RatioLR+, Positive LR
A diagnostic test measure expressing how much a positive result increases the odds that a patient truly has the condition tested for.
Positive Predictive ValuePPV, True-Positive Share
The probability that an individual with a positive diagnostic test result truly has the condition being tested for.
Post-Test ProbabilityPost-Test Risk, Updated Diagnostic Probability
The updated probability that a patient has a condition after a diagnostic test result is known, combining pre-test probability with the likelihood ratio.
Pre-Test ProbabilityPrior Diagnostic Probability, Baseline Risk of Condition
The estimated probability that a patient has a condition before a diagnostic test result is known, based on prevalence and clinical presentation.
Precision TherapyMolecularly Targeted Treatment, Biomarker-Directed Therapy
A treatment targeting a specific molecular or genetic feature of a patient's disease, closely related to personalised therapy but emphasising the biological targeting mechanism.
PriceMarket Rate, Selling Amount
The amount of money required to purchase a good or service in a market transaction.
Primary Care CoverageGP Coverage, First-Contact Coverage
A measure of the extent to which a population has access to basic, first-contact healthcare services, a foundational coverage indicator.
Primary Care ModelPatient-Centred Medical Home, PCMH
An organisational approach emphasising accessible, community-based, first-contact care as the health system's foundation, with primary care coordinating overall needs.
Primary HealthcarePrimary Health Care, Comprehensive First-Level Care
An approach to health system organisation emphasising accessible, community-based, first-contact care as the foundation of the entire system.
Prophylactic TherapyChemoprevention Regimen, Preventive Drug Course
Treatment given specifically to prevent a disease or complication before any evidence it has begun to develop, such as pre-surgical antibiotics.

Q

Quality UncertaintyLemons Problem, Hidden-Quality Problem
A condition in which buyers cannot reliably judge a good's quality before purchase, risking markets dominated by lower-quality offerings.

R

Random Number GenerationRNG, Random Draw Generation
Random number generation supplies the uncertain draws used in probabilistic sensitivity analysis, microsimulation, discrete-event simulation, bootstrap procedures, and other stochastic analyses.
Rapid Cycle ImprovementRCI, Rapid-Cycle QI
An approach emphasising testing small, incremental changes quickly through successive plan-do-study-act cycles, allowing rapid learning and adjustment.
Recovery ModelRecovery Approach, Recovery-Oriented Care
A mental health treatment approach emphasising a person's own goals, strengths, and capacity for a meaningful life, rather than symptom elimination alone.
Registration TrialConfirmatory Licensing Trial, Approval Study
A trial specifically designed to generate the evidence required for a regulatory marketing application, typically synonymous with a pivotal phase III trial.
Regression TestingRe-Test Validation, Change-Verification Testing
A verification technique re-running a previously validated set of test cases after a model has been modified, to confirm no new errors appeared.
Rehabilitation Service CoverageRehab Benefit Coverage, PT-OT Coverage
A measure of the extent to which a population has access to needed physical, occupational, and other rehabilitative healthcare services.
Repeated Measures AnalysisRM-ANOVA, Within-Subject Analysis
A statistical approach analysing data in which the same outcome has been measured multiple times on the same individuals, accounting for correlation.
ReplicationSimulation Replications, Monte Carlo Runs
Running multiple independent repetitions of a stochastic simulation, each with its own randomly sampled numbers, to estimate output variability and confidence intervals.
Reservation PriceReserve Price, Maximum Acceptable Price
The maximum price a buyer is willing to pay for a good or service before deciding not to purchase it at all.
Retrospective PaymentRetrospective Reimbursement, Cost-Reimbursement Payment
A methodology reimbursing a provider based on actual costs or charges incurred, determined after care has been provided, unlike prospective payment.
Retrospective ReviewPost-Service Review, Look-Back Review
A utilisation management assessment conducted after a service has been delivered, evaluating whether it was consistent with coverage criteria.
Right CensoringRight-Censored Data, Type I Censoring
The most common form of censoring, occurring when follow-up ends or a patient is lost before the event of interest has occurred.

S

Salvage TherapySalvage Treatment, Late-Line Therapy
Treatment given to patients whose disease has progressed or failed to respond despite prior standard treatment, typically a later line of therapy.
Search GoodSearch Product, Inspection Good
A good whose quality can be assessed by the consumer before purchase, unlike an experience good evaluated only after consumption.
Second-Line TherapySecond-Line Treatment, 2L Therapy
A treatment used after a patient's first-line treatment has failed to control disease adequately or has been discontinued due to intolerance.
Self-Funded PlanSelf-Funded Health Plan, ASO Arrangement
An arrangement where an employer itself assumes financial risk for employee healthcare claims, rather than purchasing a fully insured policy.
Specialist Care CoverageSpecialist Coverage, Specialised Care Coverage
A measure of the extent to which a population has access to needed specialised medical care beyond basic primary care.
SpinResult Overstatement, Interpretation Bias
The practice of presenting research results, especially non-significant primary outcomes, in a way that emphasises secondary findings to convey false favourability.
Stable DiseaseSD, Disease Stability
A standardised tumour response classification for a tumour that has neither shrunk enough for a partial response nor grown enough for progressive disease.
Stop-Loss InsuranceExcess Loss Insurance, Loss-Cap Cover
A reinsurance type purchased by self-insured employers to protect against unexpectedly high claims costs, from a single case or aggregate total.
Subsidy DesignSubsidy Structuring, Grant Design
The specific structure of a financial assistance programme, including eligibility criteria, subsidy amount, and how it phases out as income rises.
Substitution EffectSubstitution Response, Relative-Price Effect
The change in quantity of a good consumed that results purely from a change in its relative price, holding purchasing power constant.
Summative EvaluationOutcome Evaluation, Summative Assessment
An evaluation conducted after a programme has been fully implemented, intended to assess its overall effectiveness and inform a final judgement.
Sunk CostUnrecoverable Cost, Retrospective Cost
A cost that has already been incurred and cannot be recovered regardless of future decisions.
Surgical Safety CoverageSurgical Safety Benefit, Safe-Surgery Cover
A measure of the extent to which a population has access to safe surgical services, covering both availability and quality standards.

T

Technology MaturityMaturity Stage, Technology Readiness
The degree to which a technology has an established evidence base and standardised, predictable clinical use, unlike a newly emerging one.
Test SetHoldout Set, Test Data
A subset of data withheld from model building, used afterward to evaluate how well the model performs on data it has not seen.
Thrombolysis EconomicsEconomics of Thrombolysis, Clot-Buster Economics
The application of health economic evaluation to clot-dissolving medication used in emergency stroke and heart attack treatment, emphasising treatment speed.
TIA EconomicsTransient Ischaemic Attack Economics, Mini-Stroke Economics
The application of health economic evaluation to transient ischaemic attacks, brief stroke-like episodes warning of future stroke risk, emphasising rapid diagnosis.
Time with SymptomsSymptomatic Time, Time in Symptomatic State
A phase within the Q-TWiST framework representing the period during which a patient experiences symptoms of disease progression or treatment toxicity.
Time Without Symptoms of ProgressionTWiST, Symptom-Free Progression-Free Time
A phase within the Q-TWiST framework covering the period free of significant treatment toxicity or disease progression symptoms, typically weighted highest.
Total Quality ManagementTQM, Organisation-Wide Quality Management
A comprehensive organisational philosophy emphasising continuous improvement, customer focus, and employee engagement in identifying and addressing quality problems.
Treatment Access
A healthcare access dimension concerning patients' ability to obtain a needed treatment once a clinical decision has been made to pursue it.

U

UnderinsuranceUnderinsured Status, Inadequate Coverage
A situation where an individual has insurance that is insufficiently comprehensive to provide adequate financial protection, often from high deductibles or limited benefits.

V

Vision Care CoverageEye Care Coverage, Optical Coverage
A measure of the extent to which a population has access to needed eye care services, including vision correction.
Volume DiscountQuantity Discount, Bulk Discount
A price reduction offered based on the quantity of a product purchased, with larger volumes typically qualifying for a greater discount.
Volume-Based PricingVolume Pricing, Quantity-Based Pricing
A pricing structure where the price paid per unit depends on total quantity purchased or used, typically decreasing as volume increases.